Please login to the form below

Scott Gottlieb

This page shows the latest Scott Gottlieb news and features for those working in and with pharma, biotech and healthcare.

Mega-mergers dominate as buoyant markets lift biopharma

now former FDA commissioner Scott Gottlieb.

Latest news

FDA will maintain the pace, vows Woodcock, but warns of skills gap

Top official unconcerned by dip in approval rate. The departure of Scott Gottlieb in April robbed the FDA of one of its most dynamic ever Commissioners, and industry observers have been ... Before Gottlieb departed earlier this year, he unveiled a new
Ex-FDA chief Gottlieb's quick move to pharma raises eyebrows

Will join Pfizer board. Just 83 days after leaving his Commissioner role at the FDA, Scott Gottlieb has joined the board of big pharma group Pfizer. ... We are fortunate to have D. Gottlieb join Pfizer’s Board of Directors,” said Pfizer executive
Verily unveils next-gen trials alliance with Novartis, Pfizer

There is also no doubt that regulators are keen to see the industry update its practices. Shortly before he stepped down as FDA commissioner earlier this year, Scott Gottlieb expressed his
Sanofi joins Lilly in insulin price cut, but lawmakers have lost patience

Last week, outgoing FDA Commissioner Scott Gottlieb said the regulator would change how insulin is regulated to make it easier for biosimilar insulin products to come to market.
Roche says ‘discovery proteomics’ is heading for clinical trials

Proteomics was one technology name-checked by outgoing FDA Commissioner Scott Gottlieb in a recent statement admonishing the pharma industry for not adopting innovative approaches to clinical trials.

More from news
Approximately 5 fully matching, plus 43 partially matching documents found.

Latest Intelligence

Streamlining clinical trials – why better data use is key

Dr Scott Gottlieb’s brief, energetic tenure as US FDA Commissioner is likely to shape agency oversight of the pharmaceutical industry for years to come, particularly in relation to clinical development. ... To embrace innovations like blockchain, as
Cell and gene therapy

Interest in cell and gene therapies is undeniable. In January, US FDA Commissioner Scott Gottlieb outlined policies designed to accommodate an anticipated surge in cell and gene therapy submissions. ... Gottlieb highlighted manufacture as a challenge

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Account Manager – Healthcare advertising: Salary TBC

Account Director – UK Office: Excellent salary and benefits

Subscribe to our email news alerts

PMHub

Add my company

Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...